The development and microarray analysis of a novel radioresistant breast cancer cell line

被引：0
|
作者：
Qutob, O. [1 ]
Watson, M. B. [1 ]
Beavis, A. W. [1 ]
Lind, M. J. [1 ]
Drew, P. J. [1 ]
Cawkwell, L. [1 ]
机构：
[1] Univ Hull, Hull York Med Sch, Postgrad Med Inst, Canc Biol Proteom Grp, Kingston Upon Hull HU6 7RX, N Humberside, England
来源：
ANNALS OF SURGICAL ONCOLOGY | 2007年 / 14卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 87
页数：2
相关论文
共 50 条
  • [21] Cortactin in Breast Cancer: Analysis with Tissue Microarray
    Sheen-Chen, Shyr-Ming
    Huang, Chun-Ying
    Liu, Yu-Yin
    Huang, Chao-Cheng
    Tang, Rei-Ping
    ANTICANCER RESEARCH, 2011, 31 (01) : 293 - 297
  • [22] A microarray approach to translational medicine in breast cancer: How representative are cell line models of clinical conditions?
    Mehta, Jai Prakash
    O'Driscoll, Lorraine
    Barron, Niall
    Clynes, Martin
    Doolan, Padraig
    ANTICANCER RESEARCH, 2007, 27 (3A) : 1295 - 1300
  • [23] How representative are cell line models to clinical conditions? A microarray approach to translational medicine in breast cancer
    Mehta, Jai Prakash
    Doolan, Padraig
    Clynes, Martin
    ANTICANCER RESEARCH, 2007, 27 (3A) : 1383 - 1383
  • [24] Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer
    Beyer S.J.
    Zhang X.
    Jimenez R.E.
    Lee M.-L.T.
    Richardson A.L.
    Huang K.
    Jhiang S.M.
    BMC Research Notes, 4 (1)
  • [25] Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient
    Julie Johnson
    Darrell C. Bessette
    Jodi M. Saunus
    Chanel E. Smart
    Sarah Song
    Rebecca L. Johnston
    Sibylle Cocciardi
    Esdy N. Rozali
    Cameron N. Johnstone
    Ana Christina Vargas
    Stephen H. Kazakoff
    Victorian Cancer BioBank
    Kum Kum Khanna
    Sunil R. Lakhani
    Georgia Chenevix-Trench
    Peter T. Simpson
    Katia Nones
    Nicola Waddell
    Fares Al-Ejeh
    Breast Cancer Research and Treatment, 2018, 170 : 179 - 188
  • [26] Characterization of FaDu-R, a radioresistant head and neck cancer cell line, and cancer stem cells
    Cho, Kwang-Jae
    Park, Eun-Ji
    Kim, Min-Sik
    Joo, Young-Hoon
    AURIS NASUS LARYNX, 2018, 45 (03) : 566 - 573
  • [27] Cross-Resistance of Acquired Radioresistant Colorectal Cancer Cell Line to gefitinib and regorafenib
    Afshar, Saeid
    Pashaki, Abdolazim Sedighi
    Najafi, Rezvan
    Nikzad, Safoora
    Amini, Razieh
    Shabab, Nooshin
    Khiabanchian, Omid
    Tanzadehpanah, Hamid
    Saidijam, Massoud
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2020, 45 (01) : 50 - 58
  • [28] NMD microarray analysis of mutated genes in breast cancer
    Muggerud, Aslaug Aa
    Wolf, Maija
    Edgren, Henrik
    Kilpinen, Sami
    Sorlie, Therese
    Kallioniemi, Olli
    CANCER RESEARCH, 2006, 66 (08)
  • [29] Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient
    Johnson, Julie
    Bessette, Darrell C.
    Saunus, Jodi M.
    Smart, Chanel E.
    Song, Sarah
    Johnston, Rebecca L.
    Cocciardi, Sibylle
    Rozali, Esdy N.
    Johnstone, Cameron N.
    Vargas, Ana Christina
    Kazakoff, Stephen H.
    Khanna, Kum Kum
    Lakhani, Sunil R.
    Chenevix-Trench, Georgia
    Simpson, Peter T.
    Nones, Katia
    Waddell, Nicola
    Al-Ejeh, Fares
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (01) : 179 - 188
  • [30] Development of novel combination of Imatinib and Thymoquinone on colon cancer cell line
    Omran, M. M.
    Thabet, N. A.
    El-Khouly, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S249 - S249
12345